UNIVERSITY OF WASHINGTON

Global rheumatoid arthritis incidence increased 13.2% from 1990 to 2021, affecting 17.9 million people worldwide by 2021, with significant regional disparities and a shift toward younger age groups.

Men experience higher mortality rates from 13 of the top 20 global health conditions, with COVID-19 and heart disease showing 45% higher illness and death rates compared to women.

New AI technology developed at University of Washington has identified hundreds of undiagnosed fatty liver disease cases by analyzing existing imaging scans, with 83% of patients with evidence of the disease lacking formal diagnosis.

Recent research shows that ozone pollution exposure during a child's first two years increases asthma risk by 31% at ages 4-6, highlighting the need for long-term ozone regulation.

New research from Kaiser Permanente Southern California reveals wildfire smoke exposure significantly increases dementia risk, with each one-microgram-per-square-meter increase in wildfire-generated PM 2.5 associated with an 18% higher risk of dementia diagnosis.

Four out of five Americans are projected to be overweight or obese by 2050, with obesity rates increasing faster than overweight, according to a comprehensive study published in The Lancet.

New research identifies four critical limitations in comparing drug launch prices with value-based prices derived from conventional cost-effectiveness analyses, complicating policy decisions.

The Seqfirst-neo study reveals that using exclusion-based criteria for genomic testing in NICUs could significantly increase diagnosis rates, with 49.2% of tested infants receiving precise genetic diagnoses.

A systematic literature review presented at ASH 2024 demonstrates that clinical trials significantly underestimate the health-related quality of life burden in relapsed/refractory multiple myeloma patients compared to real-world settings.

The U.S. Preventive Services Task Force has issued new recommendations for osteoporosis screening, maintaining its guidance for women 65 and older while specifying DXA testing as the preferred screening method.